The Study of Surgery,Chemotherapy and Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer.
Evaluate the feasibility ,safety and efficacy of Surgeryï¼ŒChemotherapy in Combination with Autologous T cells-Based Immunotherapy for Advanced Gastric Cancer.
Gastric Cancer.
BIOLOGICAL: Autologous T cells-Based Immunotherapy
Progression-Free-Survival(PFS), The primary objective is to assess progression free survival (PFS)., 24months
Incidences of adverse events or serious adverse events, 24months
Safety:AE/SAE Efficacy:immunologic function;FPS